Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Imig

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
The American Journal of Pathology|August 25, 2007
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertensionMatthew J Socha, Marlina Manhiani, Neveen Said, et al.
Journal of Cardiovascular Pharmacology|September 23, 2017
Orally Active Epoxyeicosatrienoic Acid AnalogsWilliam B Campbell, John D Imig, James M Schmitz, et al.
Nephron. Physiology|August 29, 2009
Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout miceRaymond Quigley, Sumana Chakravarty, Xueying Zhao, et al.
British Journal of Pharmacology|October 19, 2005
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelinEdward W Inscho, John D Imig, Anthony K Cook, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertensionJohn D Imig, Xueying Zhao, Jorge H Capdevila, et al.
Frontiers in Immunology|January 18, 2024
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosisMd Abdul Hye Khan, Benjamin Nolan, Anna Stavniichuk, et al.
Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia|November 30, 2020
A SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASEA Stavniichuk, O Savchuk, Abdul Hye Khan, et al.
American Journal of Physiology. Renal Physiology|August 29, 2014
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammationJinu Kim, John D Imig, Jun Yang, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Kidney & Blood Pressure Research|January 7, 2024
Kidney Injury by Unilateral Ureteral Obstruction in Mice Lacks Sex DifferencesSamaneh Goorani, Abdul Hye Khan, Abhishek Mishra, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
The American Journal of Pathology|August 25, 2007
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertensionMatthew J Socha, Marlina Manhiani, Neveen Said, et al.
Journal of Cardiovascular Pharmacology|September 23, 2017
Orally Active Epoxyeicosatrienoic Acid AnalogsWilliam B Campbell, John D Imig, James M Schmitz, et al.
Nephron. Physiology|August 29, 2009
Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout miceRaymond Quigley, Sumana Chakravarty, Xueying Zhao, et al.
British Journal of Pharmacology|October 19, 2005
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelinEdward W Inscho, John D Imig, Anthony K Cook, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertensionJohn D Imig, Xueying Zhao, Jorge H Capdevila, et al.
Frontiers in Immunology|January 18, 2024
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosisMd Abdul Hye Khan, Benjamin Nolan, Anna Stavniichuk, et al.
Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia|November 30, 2020
A SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASEA Stavniichuk, O Savchuk, Abdul Hye Khan, et al.
American Journal of Physiology. Renal Physiology|August 29, 2014
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammationJinu Kim, John D Imig, Jun Yang, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Kidney & Blood Pressure Research|January 7, 2024
Kidney Injury by Unilateral Ureteral Obstruction in Mice Lacks Sex DifferencesSamaneh Goorani, Abdul Hye Khan, Abhishek Mishra, et al.
Pageof 20